Location History:
- Dallas, TX (US) (2003 - 2016)
- Jupiter, FL (US) (2013 - 2019)
Company Filing History:
Years Active: 2003-2019
Title: The Innovative Contributions of Thomas Kodadek
Introduction
Thomas Kodadek is a prominent inventor based in Jupiter, Florida, known for his significant contributions to the field of biochemistry and drug discovery. With a total of 12 patents to his name, Kodadek has made remarkable advancements in the synthesis of novel compounds that have potential applications in biological research and pharmaceuticals.
Latest Patents
Kodadek's latest patents include groundbreaking work on the synthesis of libraries of peptide tertiary amides. This patent focuses on a novel class of peptide-like oligomers known as peptide tertiary amides (PTAs). The disclosure outlines synthetic routes for the preparation of large combinatorial libraries of these compounds, which serve as high-affinity and selective protein ligands. These ligands are valuable tools for biological research and can lead to the development of new drugs. Another significant patent involves chiral oligomeric pentenoate amides, which are bio-oligomer mimetics characterized by a high degree of conformational rigidity. This rigidity is crucial for designing molecules that exhibit high affinities for biological receptors and enzymes. The invention provides a method for preparing these chiral compounds, which can be utilized to explore biological systems.
Career Highlights
Throughout his career, Thomas Kodadek has worked with esteemed organizations, including the University of Texas System and Opko Pharmaceuticals, LLC. His work has significantly impacted the field of drug discovery and biochemistry, leading to innovative solutions and advancements.
Collaborations
Kodadek has collaborated with notable individuals in his field, including Phillip Frost and D. Gomika Udugamasooriya. These collaborations have further enhanced his research and contributions to the scientific community.
Conclusion
Thomas Kodadek's innovative work in the synthesis of peptide-like oligomers and bio-oligomer mimetics showcases his dedication to advancing drug discovery and biological research. His contributions continue to influence the field and pave the way for future innovations.
